Dalian, China

Xiaojing Yu


 

Average Co-Inventor Count = 12.0

ph-index = 1


Company Filing History:

goldMedal2 out of 832,843 
Other
 patents

Years Active: 2019-2021

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations of Xiaojing Yu in Viral Disease Treatment

Introduction

Xiaojing Yu is an accomplished inventor based in Dalian, China. He has made significant contributions to the field of medicine, particularly in the development of antiviral drugs. His innovative work focuses on the application of natural compounds to combat viral diseases.

Latest Patents

Xiaojing Yu holds 2 patents related to the application of a phillyrin/phillygeninin composition in preparing medicines or health care products for alleviating or treating viral diseases. His inventions disclose a composition of phillyrin and phillygeninin that has shown significant treatment effects on various viral infections, including viral influenza and pneumonia. The composition is characterized by its quick action and minimal toxic side effects, making it a promising antiviral drug and health product. This invention is suitable for industrial production and easy to promote, providing a new approach to preventing and treating viral diseases.

Career Highlights

Throughout his career, Xiaojing Yu has worked on groundbreaking research that has the potential to improve public health. His focus on developing effective antiviral treatments showcases his commitment to addressing pressing health challenges.

Collaborations

Xiaojing has collaborated with notable individuals in his field, including Li Fu and Mingming Lu. These partnerships have contributed to the advancement of his research and the successful development of his inventions.

Conclusion

Xiaojing Yu's innovative work in the field of antiviral treatments highlights the importance of research and development in combating viral diseases. His contributions are paving the way for safer and more effective health care solutions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…